{"id":"https://openalex.org/W7203590700","doi":null,"title":"EFFICACY OF PERINDOPRIL IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION.","display_name":"EFFICACY OF PERINDOPRIL IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION.","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7203590700","pmid":"https://pubmed.ncbi.nlm.nih.gov/42603340"},"language":"en","primary_location":{"id":"pmid:42603340","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42603340","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080952331","display_name":"Natia Nazghaidze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145733","display_name":"David Agmashenebeli University of Georgia","ror":"https://ror.org/03xpxn276","country_code":"GE","type":"education","lineage":["https://openalex.org/I4210145733"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"N Nazghaidze","raw_affiliation_strings":["1David Aghmashenebeli University of Georgia - SDASU; Department of Cardiology, \"Caucasus Medical Center\", Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Aghmashenebeli University of Georgia - SDASU; Department of Cardiology, \"Caucasus Medical Center\", Tbilisi, Georgia","institution_ids":["https://openalex.org/I4210145733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068920381","display_name":"Sh Petriashvili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4396570552","display_name":"East-West University","ror":"https://ror.org/01597w461","country_code":"GE","type":"education","lineage":["https://openalex.org/I4396570552"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"Sh Petriashvili","raw_affiliation_strings":["2Al. Aladashvili Clinic, East-West University, Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Al. Aladashvili Clinic, East-West University, Tbilisi, Georgia","institution_ids":["https://openalex.org/I4396570552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022539298","display_name":"Rusudan Agladze","orcid":"https://orcid.org/0009-0006-8533-6225","observed_orcids":["https://orcid.org/0009-0006-8533-6225"]},"institutions":[{"id":"https://openalex.org/I4210137567","display_name":"David Tvildiani Medical University","ror":"https://ror.org/04w893s72","country_code":"GE","type":"education","lineage":["https://openalex.org/I4210137567"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"R Agladze","raw_affiliation_strings":["3Department of Cardiology, Bokhua Memorial Cardiovascular Center; David Tvildiani Medical University, Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Cardiology, Bokhua Memorial Cardiovascular Center; David Tvildiani Medical University, Tbilisi, Georgia","institution_ids":["https://openalex.org/I4210137567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139310777","display_name":"N Kuridze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267676","display_name":"Akademikos G. Chapidzis Sakhelobis Gadaudebeli Kardiologiis Tsentri","ror":"https://ror.org/03v3hg546","country_code":"GE","type":"healthcare","lineage":["https://openalex.org/I4405267676"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"N Kuridze","raw_affiliation_strings":["4Inpatient Unit of Cardiac Surgery Department, G. Chapidze Emergency Cardiology Center; Caucasus Medicine school, Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Inpatient Unit of Cardiac Surgery Department, G. Chapidze Emergency Cardiology Center; Caucasus Medicine school, Tbilisi, Georgia","institution_ids":["https://openalex.org/I4405267676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082994431","display_name":"Zviad Kereselidze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Kereselidze","raw_affiliation_strings":["5Intensive Care Unit, \"Tbilisi Heart Center\", Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Intensive Care Unit, \"Tbilisi Heart Center\", Georgia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5147311726","display_name":"S Ungiadze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267676","display_name":"Akademikos G. Chapidzis Sakhelobis Gadaudebeli Kardiologiis Tsentri","ror":"https://ror.org/03v3hg546","country_code":"GE","type":"healthcare","lineage":["https://openalex.org/I4405267676"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"S Ungiadze","raw_affiliation_strings":["6Chapidze Heart Center, Atherosclerosis Working Group of the Georgian Society of Cardiology, Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Chapidze Heart Center, Atherosclerosis Working Group of the Georgian Society of Cardiology, Tbilisi, Georgia","institution_ids":["https://openalex.org/I4405267676"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"375","first_page":"238","last_page":"247"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9750000238418579},{"id":"https://openalex.org/keywords/perindopril","display_name":"perindopril","score":1.0},{"id":"https://openalex.org/keywords/sacubitril-valsartan","display_name":"sacubitril/valsartan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cardiac-reverse-remodeling","display_name":"reverse cardiac remodeling","score":0.6869999766349792},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9580000042915344},{"id":"https://openalex.org/keywords/nyha-functional-class","display_name":"NYHA functional class","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pulmonary-artery-systolic-pressure","display_name":"pulmonary artery systolic pressure","score":0.9509999752044678},{"id":"https://openalex.org/keywords/guideline-directed-medical-therapy","display_name":"guideline-directed medical therapy","score":0.902999997138977},{"id":"https://openalex.org/keywords/de-novo-heart-failure","display_name":"de novo heart failure","score":0.7369999885559082},{"id":"https://openalex.org/keywords/heart-failure-prognosis","display_name":"heart failure prognosis","score":0.42500001192092896},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.3630000054836273},{"id":"https://openalex.org/keywords/echocardiography","display_name":"echocardiography","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2779200603","wikidata":"https://www.wikidata.org/wiki/Q277785","display_name":"Perindopril","level":3,"score":0.9596999883651733},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9101999998092651},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.829800009727478},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7879999876022339},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7864000201225281},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7771000266075134},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4805000126361847},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4223000109195709},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.3752000033855438},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.34950000047683716},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.33649998903274536},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.33410000801086426},{"id":"https://openalex.org/C2779537366","wikidata":"https://www.wikidata.org/wiki/Q7920323","display_name":"Ventricular remodeling","level":3,"score":0.3043999969959259},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.29409998655319214},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.27489998936653137},{"id":"https://openalex.org/C2780940725","wikidata":"https://www.wikidata.org/wiki/Q206280","display_name":"Pulmonary artery","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.26489999890327454},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2540999948978424}],"mesh":[{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000613","descriptor_name":"Aminobutyrates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020257","descriptor_name":"Ventricular Remodeling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020913","descriptor_name":"Perindopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:42603340","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42603340","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386209736","https://openalex.org/W7159615266","https://openalex.org/W4392565332","https://openalex.org/W2805015756","https://openalex.org/W4205652352","https://openalex.org/W4399743738","https://openalex.org/W3214495727","https://openalex.org/W4401907831","https://openalex.org/W3193435473","https://openalex.org/W7169477676"],"abstract_inverted_index":{"BACKGROUND/INTRODUCTION:":[0],"Heart":[1,114],"failure":[2,21,236],"with":[3,54,91,188,286,299,324],"reduced":[4,172],"ejection":[5],"fraction":[6],"(HFrEF)":[7],"represents":[8],"a":[9,39,50,55,320],"major":[10,189],"global":[11],"health":[12],"burden,":[13],"accounting":[14],"for":[15],"approximately":[16],"half":[17],"of":[18,46,85,242],"all":[19],"heart":[20,235],"cases":[22],"and":[23,30,82,118,123,131,136,149,160,178,196,209,232,292,303,312],"characterized":[24],"by":[25],"high":[26],"mortality,":[27],"frequent":[28],"hospitalizations,":[29],"progressive":[31],"cardiac":[32,80,295,310],"remodeling.":[33],"Angiotensin-converting":[34],"enzyme":[35],"(ACE)":[36],"inhibitors":[37],"constitute":[38],"foundational":[40],"cornerstone":[41],"in":[42,68,89,93,158,205,214,252,260,297,308,335],"the":[43,76,206,215],"therapeutic":[44,77,333],"management":[45],"HFrEF.":[47,300],"Perindopril":[48,129,282],"is":[49,284],"long-acting":[51],"ACE":[52],"inhibitor":[53],"highly":[56],"favorable":[57,321],"safety":[58,322],"profile;":[59],"however,":[60],"robust":[61],"clinical":[62,83,95,288],"data":[63],"evaluating":[64],"its":[65,328],"specific":[66],"efficacy":[67,307],"HFrEF":[69,92,104,336],"cohorts":[70,247],"remain":[71],"scarce.":[72],"AIM:":[73],"To":[74],"evaluate":[75],"efficacy,":[78],"reverse":[79,190,294],"remodeling,":[81],"outcomes":[84],"perindopril":[86,207,302,318],"versus":[87],"sacubitril/valsartan":[88,216,304],"patients":[90,105,298],"routine":[94],"practice.":[96],"METHODS:":[97],"This":[98],"retrospective":[99],"cohort":[100],"study":[101],"included":[102,156],"214":[103],"(LVEF<40%,":[106],"mean":[107],"age":[108],"64.8\u00b111.0":[109],"years)":[110],"treated":[111],"at":[112,141],"Tbilisi":[113],"Center":[115],"between":[116,193,275],"2018":[117],"2025.":[119],"Patients":[120],"received":[121],"GDMT":[122],"were":[124,139,239,266],"divided":[125],"into":[126],"two":[127],"groups:":[128],"(n=118)":[130],"Sacubitril/Valsartan":[132],"(n=96).":[133],"Clinical,":[134],"echocardiographic,":[135],"biochemical":[137],"metrics":[138],"assessed":[140],"baseline":[142,228],"(Visit":[143,147,152],"1),":[144],"2-3":[145],"weeks":[146],"2),":[148],"3-6":[150],"months":[151],"3).":[153],"Primary":[154],"endpoints":[155],"changes":[157,259],"LVEF":[159,199,229,290],"NYHA":[161,253,314],"functional":[162,254,315],"class.":[163],"RESULTS:":[164],"\u2022":[165,198,218,245],"Both":[166,246,301],"treatment":[167,224],"strategies":[168],"significantly":[169,274],"improved":[170],"LVEF,":[171],"left":[173],"ventricular":[174],"dimensions":[175,311],"(LVEDD,":[176],"LVESD),":[177],"decreased":[179],"pulmonary":[180],"artery":[181],"systolic":[182],"pressure":[183],"(ANOVA":[184],"p":[185],"<":[186],"0.01),":[187],"remodeling":[191,296],"occurring":[192],"Visits":[194],"1":[195],"2.":[197],"increased":[200],"from":[201,210],"34.3\u00b13.9%":[202],"to":[203,212],"41.3\u00b17.4%":[204],"group":[208,225],"30.8\u00b15.2%":[211],"33.8\u00b18.1%":[213],"group.":[217],"In":[219],"multivariable":[220],"linear":[221],"regression":[222],"analysis,":[223],"(B=-3.170,":[226],"p=0.004),":[227],"(B=0.381,":[230],"p=0.005),":[231],"de":[233],"novo":[234],"(B=2.966,":[237],"p=0.005)":[238],"independent":[240],"predictors":[241],"follow-up":[243],"LVEF.":[244],"showed":[248],"significant":[249,258,287],"longitudinal":[250],"optimization":[251],"class":[255],"(p<0.001).":[256],"No":[257],"serum":[261],"potassium":[262],"or":[263],"renal":[264],"function":[265],"observed.":[267],"One-year":[268],"all-cause":[269],"mortality":[270],"did":[271],"not":[272],"differ":[273],"groups":[276],"(33.1%":[277],"vs.":[278],"22.9%,":[279],"p=0.103).":[280],"CONCLUSION:":[281],"therapy":[283],"associated":[285],"improvement,":[289],"recovery,":[291],"positive":[293],"demonstrate":[305],"comparable":[306],"reducing":[309],"optimizing":[313],"status.":[316],"Furthermore,":[317],"maintains":[319],"profile":[323],"low":[325],"nephrotoxicity,":[326],"confirming":[327],"potential":[329],"as":[330],"an":[331],"effective":[332],"option":[334],"management.":[337]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-08-17T00:00:00"}